Showing results (1461-1470 of 1,479) with videos related to
Sort By:
Pageof 148
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|March 6, 2026
Impact of symptom duration on the effectiveness of intradiscal condoliase injection for lumbar disc herniation: A multicenter retrospective studyKota Watanabe, Yohei Takahashi, Takehiro Michikawa, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|July 14, 2026
Does pretreatment Pfirrmann grade modify response to intradiscal condoliase injection for lumbar disc herniation?Kota Watanabe, Yohei Takahashi, Takehiro Michikawa, et al.Nature Materials|April 11, 2024
A correlated ferromagnetic polar metal by designJianbing Zhang, Shengchun Shen, Danilo Puggioni, et al.Nature Biotechnology|February 12, 2020
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapyDavid G Millar, Rakesh R Ramjiawan, Kosuke Kawaguchi, et al.Science Translational Medicine|August 21, 2024
Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapiesZhen Lu, Ioannis Verginadis, Motofumi Kumazoe, et al.JTO Clinical and Research Reports|December 4, 2023
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Shigeru Tanzawa, Toshihiro Misumi, et al.Internal Medicine (Tokyo, Japan)|November 3, 2022
Conventional and Kampo Medicine Treatment for Mild-to-moderate COVID-19: A Multicenter, Retrospective, Observational Study by the Integrative Management in Japan for Epidemic Disease (IMJEDI Study-observation)Shin Takayama, Tetsuhiro Yoshino, Sayaka Koizumi, et al.Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.Nature|April 3, 2004
The decline and fate of an iron-induced subarctic phytoplankton bloomPhilip W Boyd, Cliff S Law, C S Wong, et al.Therapeutic Advances in Medical Oncology|March 17, 2025
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA studyFumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi, et al.Pageof 148